• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER INTERNATIONAL INC. CLEARLINK; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER INTERNATIONAL INC. CLEARLINK; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Catalog Number 2H8603
Medical Device Problem Codes Crack (1135); Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
E1: initial reporter phone no.(b)(6).G1: device manufacturer address 1: 600 mts.Oeste de entrada, principal ave.Las americas, parque industrial.Should additional relevant information become available, a supplemental report will be submitted.
 
Event or Problem Description
It was reported the filters in three (3) clearlink system non-dehp extension sets appeared to be cracked which subsequently leaked.The events occurred during unknown process steps.There was no report of patient injury or medical intervention associated with this event.No additional information is available.
 
Additional Manufacturer Narrative
H11: three (3) devices were received for evaluation.Visual inspection of all three devices did not identify any abnormalities that could have contributed to the reported condition.The sets underwent functional testing including pressure and clear passage underwater testing and leaks were observed in two of the sets.The reported condition was verified in two sets.The leaks were due to cracked/broken female connector.The cause of the leaks of sets one and two were due to non-conforming material from the supplier.There are controls in place for raw material such incoming inspection on visual, dimensional and functional testing.The third set did not leak.The reported condition was not verified.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLEARLINK
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
BAXTER INTERNATIONAL INC.
deerfield IL
Manufacturer (Section G)
BAXTER HEALTHCARE - CARTAGO
see h10
cartago 30106
CS   30106
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key19291082
Report Number1416980-2024-02213
Device Sequence Number7339866
Product Code FPA
UDI-Device Identifier00085412046433
UDI-Public(01)00085412046433(10)R18C08098(17)230308
Combination Product (Y/N)N
Initial Reporter CountryCA
PMA/510(K) Number
K952074
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 06/17/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date03/08/2023
Device Catalogue Number2H8603
Device Lot NumberR18C08098
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/16/2024
Supplement Date Received by Manufacturer06/13/2024
Initial Report FDA Received Date05/10/2024
Supplement Report FDA Received Date06/17/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/09/2018
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
NI.
Patient SexUnknown
-
-